Pharmaceutical News

RSS

New study shows XBB.1.5 COVID-19 vaccine significantly reduces hospitalizations and ICU admissions in older adults

Study evaluates the effectiveness of the XBB.1.5 COVID-19 vaccine in reducing hospitalizations and ICU admissions among vaccinated adults aged 60 and over in the Netherlands, showing a 70.7% effectiveness against hospitalization and 73.3% against ICU admission.

17 Dec 2023

New AI framework can rapidly identify new use cases for existing therapeutics

Scientists at Klick Applied Sciences have created an artificial intelligence framework that can rapidly identify new use cases for existing therapeutics, according to findings presented Friday at the NeurIPS conference that could greatly improve the drug repurposing process and transform the pharmaceutical industry.

15 Dec 2023

Blueprint Medicines announces approval of AYVAKYT for treatment of ISM patients in Europe

Blueprint Medicines Corporation today announced the European Commission has approved AYVAKYT® (avapritinib) for the treatment of adult patients with indolent systemic mastocytosis (ISM) with moderate to severe symptoms inadequately controlled on symptomatic treatment. AYVAKYT is the first and only approved therapy for people living with ISM in Europe.

15 Dec 2023

New dry powder aerosol COVID-19 vaccine shows promise against multiple virus strains

Study introduces a novel dry powder aerosol COVID-19 vaccine, showing its effectiveness in inducing strong immune responses and offering protection against various SARS-CoV-2 strains, including Omicron.

15 Dec 2023

Intranasal COVID-19 vaccine shows promise in reducing severe symptoms

Study evaluates the single-dose intranasal spray vaccine dNS1-RBD, finding it effective against symptomatic COVID-19, particularly in reducing severe symptoms and respiratory issues.

15 Dec 2023

UH researchers secure NIH grant to tackle buprenorphine's dental side effects

In the fatal world of opioid use disorder (OUD), pharmacotherapy, or using a prescribed medication to treat drug dependence, has emerged as the gold standard of treatment.

14 Dec 2023

How safe are GLP-1R agonists in early pregnancy?

JAMA Internal Medicine study examines the safety of GLP-1 receptor agonists and other second-line antidiabetic medications during early pregnancy, finding no significant increase in congenital anomalies compared to insulin use.

14 Dec 2023

Uncovering barriers to heart failure medication access for low-income patients

People who live in neighborhoods with higher levels of poverty and unemployment are less likely to fill their heart-failure drug prescriptions than those living in wealthier areas, a new study shows.

14 Dec 2023

Common oral anticoagulant rivaroxaban linked to highest risk of bleeding complications

When diagnosed with a blood clot or atrial fibrillation, patients are often prescribed anticoagulants, or blood thinners, to prevent a future clot.

14 Dec 2023

Novel drug combinations could protect snakebite victims from devastating injuries

New drug combinations could protect snakebite victims from the devastating, life-changing injuries caused by toxic venom, promising new research led by Liverpool School of Tropical Medicine suggests.

14 Dec 2023

UK drug regulators failing to protect patients from harmful weight loss

UK organizations responsible for protecting the public from prescription-only drug adverts are putting patients at risk from the harms of weight loss drugs by not enforcing the law, reveals an investigation published by The BMJ today.

14 Dec 2023

COVID-19 vaccination eased anxiety, insomnia, and depression in Chinese adults, study finds

Study reveals that COVID-19 vaccination significantly reduces the prevalence of anxiety, insomnia, and depression symptoms among Chinese adults, with vaccinated individuals reporting lower severity of these conditions compared to non-vaccinated individuals.

13 Dec 2023

Poll: Vast majority of older adults think health insurers should cover obesity medications

The vast majority of older adults – 83% -- think health insurers should cover medications that can help people with obesity manage their weight, a new poll of people age 50 to 80 finds.

13 Dec 2023

Tirzepatide shows success in maintaining weight loss in obese adults

Study finds that the anti-obesity medication tirzepatide effectively maintains weight loss in obese adults, offering a promising approach to managing obesity and related health complications.

12 Dec 2023

Adherence to second-line drugs for Type 2 diabetes can be hit or miss, study reports

Most patients with Type 2 diabetes will end up needing to add a second-line medication after metformin - the go-to primary drug for glucose management - to control their blood sugar levels.

12 Dec 2023

Synbiotic formula shows promise in reducing long COVID symptoms

Study finds that the synbiotic preparation SIM01 significantly reduces post-acute COVID-19 syndrome symptoms in patients, including fatigue, memory issues, and gastrointestinal distress, indicating its potential as a treatment for long COVID.

11 Dec 2023

Second-line diabetes drugs safe for babies? New study offers reassurance

Infants born to women with pre-gestational type 2 diabetes who take second-line non-insulin antidiabetic medications (ADMs) during pregnancy are at no higher risk of major congenital malformations (MCMs) than infants born to those who take insulin, according to a new study led by Harvard T.H. Chan School of Public Health.

11 Dec 2023

DeepMirror launches early access programme for its intuitive molecular drug design software

Innovative product enables medicinal chemists to access and integrate AI to boost productivity and creativity, to accelerate therapeutic drug discovery.

From DeepMirror 11 Dec 2023

MD Anderson and Rigel partner to expand olutasidenib evaluation in AML and other cancers

The University of Texas MD Anderson Cancer Center and Rigel Pharmaceuticals, Inc. today announced a multi-year strategic development collaboration to expand the evaluation of olutasidenib in acute myeloid leukemia (AML) and other hematologic cancers.

8 Dec 2023

Repeated mRNA vaccines supercharge immune response against COVID-19, study finds

Study published in Nature Immunology reveals that repeated mRNA COVID-19 vaccinations enhance immune response, especially in previously infected individuals, leading to a diversified and increased number of immune cell clones and a stronger ability to combat various virus strains.

7 Dec 2023

Previous
1
...
38
39
40
41
42
43
44
...
1443
Next

Pharmaceutical News

New study shows XBB.1.5 COVID-19 vaccine significantly reduces hospitalizations and ICU admissions in older adults

New AI framework can rapidly identify new use cases for existing therapeutics

Blueprint Medicines announces approval of AYVAKYT for treatment of ISM patients in Europe

New dry powder aerosol COVID-19 vaccine shows promise against multiple virus strains

Intranasal COVID-19 vaccine shows promise in reducing severe symptoms

UH researchers secure NIH grant to tackle buprenorphine's dental side effects

How safe are GLP-1R agonists in early pregnancy?

Uncovering barriers to heart failure medication access for low-income patients

Common oral anticoagulant rivaroxaban linked to highest risk of bleeding complications

Novel drug combinations could protect snakebite victims from devastating injuries

UK drug regulators failing to protect patients from harmful weight loss

COVID-19 vaccination eased anxiety, insomnia, and depression in Chinese adults, study finds

Poll: Vast majority of older adults think health insurers should cover obesity medications

Tirzepatide shows success in maintaining weight loss in obese adults

Adherence to second-line drugs for Type 2 diabetes can be hit or miss, study reports

Synbiotic formula shows promise in reducing long COVID symptoms

Second-line diabetes drugs safe for babies? New study offers reassurance

DeepMirror launches early access programme for its intuitive molecular drug design software

MD Anderson and Rigel partner to expand olutasidenib evaluation in AML and other cancers

Repeated mRNA vaccines supercharge immune response against COVID-19, study finds

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News